| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR (Put) | 12.94% | 700,000 | $432,495,000 | 300,000 | 75% | $617.85 | 13F |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 4.84% | 11,535,582 | $161,728,860 | 112,604 | 0.99% | $14.02 | 13F |
| LEGN | LEGEND BIOTECH CORP | 4.01% | 3,774,009 | $133,939,579 | 24,044 | 0.64% | $35.49 | 13F |
| KO | COCA COLA CO | 2.61% | 1,233,230 | $87,251,023 | 817,510 | 196.65% | $70.75 | 13F |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 2.48% | 2,278,000 | $82,828,080 | 253,500 | 12.52% | $36.36 | 13F |
| GE | GE AEROSPACE | 2.39% | 310,262 | $79,858,336 | 109,600 | 54.62% | $257.39 | 13F |
| NVDA | NVIDIA CORPORATION | 2.36% | 499,562 | $78,925,800 | 146,797 | 41.61% | $157.99 | 13F |
| AVBP | ARRIVENT BIOPHARMA INC | 2.22% | 3,412,788 | $74,296,395 | 1,075,292 | 46% | $21.77 | 13F |
| IMTX | IMMATICS N.V | 1.94% | 12,030,129 | $64,722,094 | 2,895,100 | 31.69% | $5.38 | 13F |
| APO | APOLLO GLOBAL MGMT INC | 1.82% | 428,460 | $60,785,620 | 31,920 | 8.05% | $141.87 | 13F |
| KALV | KALVISTA PHARMACEUTICALS INC | 1.68% | 4,955,000 | $56,016,275 | 41,988 | 0.85% | $11.31 | 13F |
| ORCL | ORACLE CORP | 1.51% | 230,728 | $50,444,063 | 4,410 | 1.95% | $218.63 | 13F |
| APLS | APELLIS PHARMACEUTICALS INC | 1.49% | 2,878,000 | $49,818,180 | 1,231,385 | 74.78% | $17.31 | 13F |
| HD | HOME DEPOT INC | 1.43% | 130,721 | $47,927,547 | 33,150 | 33.98% | $366.64 | 13F |
| KURA | KURA ONCOLOGY INC | 1.40% | 8,116,000 | $46,829,320 | 676,741 | 9.1% | $5.77 | 13F |
| BAC | BANK AMERICA CORP | 1.31% | 927,190 | $43,874,631 | 173,277 | 22.98% | $47.32 | 13F |
| CMPX | Compass Therapeutics, Inc. | 1.31% | 14,101,159 | $43,713,593 | 6,951,666 | 97.23% | 13G | |
| FERG | FERGUSON ENTERPRISES INC | 1.24% | 189,660 | $41,298,465 | 59,736 | 45.98% | $217.75 | 13F |
| BSX | BOSTON SCIENTIFIC CORP | 1.14% | 353,561 | $37,975,987 | 91,462 | 34.9% | $107.41 | 13F |
| FULC | FULCRUM THERAPEUTICS INC | 1.05% | 5,082,900 | $34,970,352 | 15,506 | 0.31% | $6.88 | 13F |
| DHR | DANAHER CORPORATION | 1.03% | 174,700 | $34,510,238 | 161,100 | 1184.56% | $197.54 | 13F |
| RCUS | ARCUS BIOSCIENCES INC | 0.90% | 3,688,858 | $30,027,304 | 1,127,954 | 44.05% | $8.14 | 13F |
| AURA | AURA BIOSCIENCES INC | 0.82% | 4,372,884 | $27,374,254 | 1,640,998 | 60.07% | $6.26 | 13F |
| MLYS | MINERALYS THERAPEUTICS INC | 0.71% | 1,744,492 | $23,602,977 | 76,733 | 4.6% | $13.53 | 13F |
| UNH | UNITEDHEALTH GROUP INC | 0.63% | 68,000 | $21,213,960 | 38,100 | 127.42% | $311.97 | 13F |
| JNJ | JOHNSON & JOHNSON | 0.61% | 132,786 | $20,283,062 | 23,400 | 21.39% | $152.75 | 13F |
| BIIB | BIOGEN INC | 0.57% | 151,890 | $19,075,865 | 31,154 | 25.8% | $125.59 | 13F |
| ERAS | ERASCA INC | 0.55% | 14,502,004 | $18,417,545 | 2,187,000 | 17.76% | $1.27 | 13F |
| MRK | MERCK & CO INC | 0.52% | 219,178 | $17,350,130 | 75,078 | 52.1% | $79.16 | 13F |
| GLUE | MONTE ROSA THERAPEUTICS INC | 0.45% | 3,360,000 | $15,153,600 | 1,796,202 | 114.86% | $4.51 | 13F |
| RCKT | ROCKET PHARMACEUTICALS INC | 0.30% | 4,143,333 | $10,151,166 | 641,333 | 18.31% | $2.45 | 13F |